Advances in Gerontology

, Volume 8, Issue 4, pp 339–346 | Cite as

Age-Related Dynamics of the Content of Matrix Metalloproteinases (MMP-1, -2, -3, and -9) and Tissue Inhibitors of Matrix Metalloproteinases (TIMP-1, -2, and -4) in Blood Plasma of Residents of the European Part of Russia’s Arctic Zone

  • L. B. KimEmail author
  • G. S. Russkikh
  • A. N. Putyatina
  • O. B. Tsypysheva


This work presents the results of the first ever study of the enzymes involved in the regulation of extracellular matrix metabolism in the European part of Russia’s Arctic zone. The content of matrix metalloproteinases (MMP-1, -2, -3, and -9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, -2, and -4) in blood plasma was evaluated in 91 men, residents of the European part of the Russian Arctic (67° N) and 14 men, residents of Western Siberia (55° N). The content of MMP-1 and MMP-9, as well as TIMP-1 and TIMP-4 in the blood plasma was higher in northerners relative to the Western Siberia residents. The age-related dynamics of MMPs and TIMPs in northerners had a multidirectional trend. We observed the maximum content of MMP-1 and MMP-9 in the group of 30–39 year olds; MMP-3, in the group of 40–49 year olds. The content of these enzymes tended to decrease with age. We found the maximum content of TIMP-1 and TIMP-2 in the group of 50–59 year olds; TIMP-4, in the group of 60–69 year olds; whereas we observed the minimum content of these enzymes in the group of young men under 29 years old. The hyaluronidase activity in plasma was minimal in the group of 30–39 year olds; it increased with age, reaching a maximum value in the group of 50–59 year olds. We can assume that the age-related imbalance in the MMP/TIMP system (a decrease in MMP content with age and vice versa, an increase in TIMP content in older age groups) is one of the reasons for the age-related increase in interstitial fibrosis and premature aging of northerners.


extracellular matrix matrix metalloproteinases tissue inhibitors of metalloproteinases aging fibrosis European North of Russia Russian Arctic 



  1. 1.
    Kim, L.B., Transport kisloroda pri adaptatsii cheloveka k usloviyam Arktiki i kardio-respiratornoi patologii (Oxygen transport in human adaptation to Arctic conditions and cardiorespiratory pathology), Novosibirsk: Nauka, 2015.Google Scholar
  2. 2.
    Kim, L.B., Kozhin, P.M., and Putyatina, A.N., The molecular marker of aging in men in the European North of Russia, Zh. Med.-Biol. Issled., 2017, vol. 5, no. 3, pp. 70–78.Google Scholar
  3. 3.
    Solov’eva, N.I., Matrix metalloproteases and their biological functions, Russ. J. Bioorg. Chem., 1998, vol. 24, no. 4, pp. 217–226.Google Scholar
  4. 4.
    Chechetkina, I.I., Specific aging processes of the employable population in the North, Extended Abstract of Cand. Sci. (Med.) Dissertation, Novosibirsk, 2007.Google Scholar
  5. 5.
    Sharaev, P.N., Strelkov, N.S., Kil’diyarova, R.R., et al., Soedinitel’naya tkan’ v detskom vozraste (Connective Tissue in Children), Izhevsk: Izhevsk. Gos. Med. Akad., 2005.Google Scholar
  6. 6.
    Apte, S.S. and Parks, W.C., Metalloproteinases: a parade of functions in matrix biology and an outlook for the future, Matrix Biol., 2015, vols. 44–46, pp. 1–6. doi 10.1016/j.matbio.2015.04.005Google Scholar
  7. 7.
    Arpino, V., Brock, M., and Gill, S.E., The role of TIMPs in regulation of extracellular matrix proteolysis, Matrix Biol., 2015, vols. 44–46, pp. 247–254. doi 10.1016/j.matbio.2015.03.005Google Scholar
  8. 8.
    Bentovim, L., Amarilio, R., and Zelzer, E., HIF1α is a central regulator of collagen hydroxylation and secretion under hypoxia during bone development, Development, 2012, vol. 139, no. 23, pp. 4473–4483. doi 10.1242/dev.083881CrossRefGoogle Scholar
  9. 9.
    Bonnema, D.D., Webb, C.S., Pennington, W.R., et al., Effects of age on plasma matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs), J. Card. Failure, 2007, vol. 13, no. 7, pp. 530–540. doi 10.1016/j.cardfail.2007.04.010CrossRefGoogle Scholar
  10. 10.
    Chen, C.-P., Yang, Y.-C., Su, T.-H., et al., Hypoxia and transforming growth factor-beta 1 act independently to increase extracellular matrix production by placental fibroblasts, J. Clin. Endocrinol. Metab., 2005, vol. 90, no. 2, pp. 1083–1090. doi 10.1210/jc. 2004-0803CrossRefGoogle Scholar
  11. 11.
    Cui, N., Hu, M., and Khalil, R.A., Biochemical and biological attributes of matrix metalloproteinases, Prog. Mol. Biol. Transl. Sci., 2017, vol. 147, pp. 1–73. doi 10.1016/bs.pmbts.2017.02.005CrossRefGoogle Scholar
  12. 12.
    Deschene, K., Celeste, C., Boerboom, D., and Theoret, C.L., Hypoxia regulates the expression of extracellular matrix associated proteins in equine dermal fibroblasts via HIF1, J. Dermatol. Sci., 2012, vol. 65, no. 1, pp. 12–18. . doi 10.1016/j.jdermsci.2011.09.006CrossRefGoogle Scholar
  13. 13.
    Distler, J.H., Jüngel, A., Pileckyte, M., et al., Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis, Arthritis Rheum., 2007, vol. 56, no. 12, pp. 4203–4215. doi 10.1002/art. 23074CrossRefGoogle Scholar
  14. 14.
    Erman, H., Gelisgen, R., Cengiz, M., et al., The association of vascular endothelial growth factor, metalloproteinases and their tissue inhibitors with cardiovascular risk factors in the metabolic syndrome, Eur. Rev. Med. Pharmacol. Sci., 2016, vol. 20, no. 6, pp. 1015–1022.Google Scholar
  15. 15.
    Giannandrea, M. and Parks, W.C., Diverse functions of matrix metalloproteinases during fibrosis, Dis. Models Mech., 2014, vol. 7, no. 2, pp. 193–203. doi 10.1242/dmm.012062CrossRefGoogle Scholar
  16. 16.
    Gonçalves, F.M., Jacob-Ferreira, A.L., Gomes, V.A., et al., Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome, Clin. Chim. Acta, 2009, vol. 403, nos. 1–2, pp. 173–177. doi 10.1016/j.cca.2009.02.013Google Scholar
  17. 17.
    Hire, J.M., Evanson, J.L., Johnson, P.C., et al., Variance of matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) concentrations in activated, concentrated platelets from healthy male donors, J. Orthop. Surg. Res., 2014, vol. 26, no. 9, pp. 29. doi 10.1186/1749-799X-9-29CrossRefGoogle Scholar
  18. 18.
    Hollborn, M., Stathopoulos, C., Steffen, A., et al., Positive feedback regulation between MMP-9 and VEGF in human RPE cells, Invest. Ophthalmol. Visual Sci., 2007, vol. 48, no. 9, pp. 4360–4367. doi 10.1167/iovs.06-1234CrossRefGoogle Scholar
  19. 19.
    Hoseini, S.M., Kalantari, A., Afarideh, M., et al., Evaluation of plasma MMP-8, MMP-9 and TIMP-1 identifies candidate cardiometabolic risk marker in metabolic syndrome: results from double-blinded nested case-control study, Metabolism, 2015, vol. 64, no. 4, pp. 527–538. doi 10.1016/j.metabol.2014.12.009CrossRefGoogle Scholar
  20. 20.
    Kangwantas, K., Pinteaux, E., and Penny, J., The extracellular matrix protein laminin-10 promotes blood-brain barrier repair after hypoxia and inflammation in vitro, J. Neuroinflammation, 2016, vol. 13, pp. 25. doi 10.1186/s12974-016-0495-9CrossRefGoogle Scholar
  21. 21.
    Kim, L.B., Belisheva, N.K., Putyatina, A.N., et al., Age-related dynamics of the main extracellular matrix components in residents of the Russian Arctic, Adv. Gerontol., 2017, vol. 7, no. 4, pp. 267–275. doi 10.1134/S2079057017040075CrossRefGoogle Scholar
  22. 22.
    Kim, L.B., Putiatina, A.N., Kozhin, P.M., et al., The correlation between collagen and lipid metabolisms in residents of the Arctic Zone of the Russian Federation, Yakut Med. J., 2016, vol. 54, no. 2, pp. 4–7.Google Scholar
  23. 23.
    Kim, L.B., Russkikh, G.S., Gevorgian, M.M., et al., Sex hormones and cardiovascular risk in male mining workers living in the European North, Hum. Physiol., 2016, vol. 42, no. 2, pp. 195–202. doi 10.1134/S0362119716020080CrossRefGoogle Scholar
  24. 24.
    Klein, T. and Bischoff, R., Physiology and pathophysiology of matrix metalloproteases, Amino Acids, 2011, vol. 41, no. 2, pp. 271–290. doi 10.1007/s00726-010-0689-xCrossRefGoogle Scholar
  25. 25.
    Komosinska-Vassev, K., Olczyk, P., Winsz-Szczotka, K., et al., Age- and gender-dependent changes in connective tissue remodeling: physiological differences in circulating MMP-3, MMP-10, TIMP-1 and TIMP-2 level, Gerontology, 2011, vol. 57, no. 1, pp. 44–52. doi 10.1159/000295775CrossRefGoogle Scholar
  26. 26.
    Liu, J. and Khalil, R.A., Matrix metalloproteinase inhibitors as investigational and therapeutic tools in unrestrained tissue remodeling and pathological disorders, Prog. Mol. Biol. Transl. Sci., 2017, vol. 148, pp. 355–420. doi 10.1016/bs.pmbts.2017.04.003CrossRefGoogle Scholar
  27. 27.
    Löffek, S., Schilling, O., and Franzke, C.W., Biological role of matrix metalloproteinases: a critical balance, Eur. Respir. J., 2011, vol. 38, no. 1, pp. 191–208. doi 10.1183/09031936.00146510Google Scholar
  28. 28.
    Manicourt, D.H., Fujimoto, N., Obata, K., and Thonar, E.J., Serum levels of collagenase, stromelysin-1, and TIMP-1. Age- and sex-related differences in normal subjects and relationship to the extent of joint involvement and serum levels of antigenic keratin sulfate in patients with osteoarthritis, Arthritis Rheum., 1994, vol. 37, no. 12, pp. 1774–1783.CrossRefGoogle Scholar
  29. 29.
    Muller, L., Monnot, C., and Germain, S., Hypoxia and extracellular matrix remodeling, in Molecular Mechanisms of Angiogenesis: From Ontogenesis to Oncogenesis, Paris: Springer-Verlag, 2014, pp. 171–197. doi 10.1007/978-2-8178-0466-8_8Google Scholar
  30. 30.
    Nagase, H., Visse, R., and Murphy, G., Structure and function of matrix metalloproteinases and TIMPs, Cardiovasc. Res., 2006, vol. 69, no. 3, pp. 562–573. doi 10.1016/j.cardiores.2005.12.002CrossRefGoogle Scholar
  31. 31.
    Navratilova, Z., Zatloukal, J., Kriegova, E., et al., Simultaneous up-regulation of matrix metalloproteinases 1, 2, 3, 7, 8, 9 and tissue inhibitors of metalloproteinases 1, 4 in serum of patients with chronic obstructive pulmonary disease, Respirology, 2012, vol. 17, no. 6, pp. 1006–1012. doi 10.1111/j.1440-1843.2012.02197.xCrossRefGoogle Scholar
  32. 32.
    Norman, J.T., Orphanides, C., Garcia, P., and Fine, L.G., Hypoxia-induced changes in extracellular matrix metabolism in renal cells, Exp. Nephrol., 1999, vol. 7, nos. 5–6, pp. 463–469. doi 10.1159/000020625Google Scholar
  33. 33.
    Oikonen, M., Wendelin-Saarenhovi, M., Siitonen, N., et al., Tissue inhibitor of matrix metalloproteinases 4 (TIMP4) in a population of young adults: relations to cardiovascular risk markers and carotid artery intima-media thickness. The Cardiovascular Risk in Young Finns Study, Scand. J. Clin. Lab. Invest., 2012, vol. 72, no. 7, pp. 540–546. doi 10.3109/00365513.2012.704065CrossRefGoogle Scholar
  34. 34.
    Orphanides, C., Fine, L.G., and Norman, J.T., Hypoxia stimulates proximal tubular cell matrix production via a TGF-beta1-independent mechanism, Kidney Int., 1997, vol. 52, no. 3, pp. 637–647.CrossRefGoogle Scholar
  35. 35.
    Tayebjee, M.H., Lip, G.Y., Blann, A.D., and Macfadyen, R.J., Effects of age, gender, ethnicity, diurnal variation and exercise on circulating levels of matrix metalloproteinases (MMP)-2 and -9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)-1 and -2, Thromb. Res., 2005, vol. 115, no. 3, pp. 205–210.CrossRefGoogle Scholar
  36. 36.
    Yamamoto, K., Murphy, G., and Troeberg, L., Extracellular regulation of metalloproteinases, Matrix Biol., 2015, vol. 44–46, pp. 255–263. doi 10.1016/j.matbio.2015.02.007Google Scholar

Copyright information

© Pleiades Publishing, Ltd. 2018

Authors and Affiliations

  • L. B. Kim
    • 1
    Email author
  • G. S. Russkikh
    • 1
    • 2
  • A. N. Putyatina
    • 1
  • O. B. Tsypysheva
    • 3
  1. 1.Research Institute of Experimental and Clinical MedicineNovosibirskRussia
  2. 2.Research Institute of BiochemistryNovosibirskRussia
  3. 3.Lovozero Central District Hospitalpos. RevdaRussia

Personalised recommendations